Results One week after right diagnostic core 23-gauge PPV her visual acuity (V.A.) was 20/25 and 20/50 in the R.E. and L.E., respectively (Fig 4). After one month gross vitreous opacities limited her V.A. to 20/50 in the R.E. Seven months later 23-gauge complete PPV and IOL implantation was performed in the L.E., where preoperative V.A. was 20/200. One week after PPV her left V.A. reached 20/25, and amyloid deposits layered onto the macula and scattered in the vitreous cavity were found in both eyes (Fig.5). In the L.E V.A. decreased to 20/70 seven months later; IOP never exceeded 20mmHg. In the R.E. severe ocular hypertension was controlled with a fixed combination of dorzolamide and timolol , and eventually amyloid material in the anterior chamber was found (Fig.6); her right V.A. ended in counting fingers owing to glaucomatous optic atrophy (Fig.5),

Complete versus Core Pars Plana Vitrectomy in a patient with TTR Tyr114Cys amyloidosis Alberto Rossetti MD*, Luigi Spedicato MD, Daniele Doro MD. Department of Neurosciences, Clinica Oculistica, University of Padua, Padua, Italy. * e-mail: alberto.rossetti@unipd.it

ROSSETTI, ALBERTO;
2013

Abstract

Results One week after right diagnostic core 23-gauge PPV her visual acuity (V.A.) was 20/25 and 20/50 in the R.E. and L.E., respectively (Fig 4). After one month gross vitreous opacities limited her V.A. to 20/50 in the R.E. Seven months later 23-gauge complete PPV and IOL implantation was performed in the L.E., where preoperative V.A. was 20/200. One week after PPV her left V.A. reached 20/25, and amyloid deposits layered onto the macula and scattered in the vitreous cavity were found in both eyes (Fig.5). In the L.E V.A. decreased to 20/70 seven months later; IOP never exceeded 20mmHg. In the R.E. severe ocular hypertension was controlled with a fixed combination of dorzolamide and timolol , and eventually amyloid material in the anterior chamber was found (Fig.6); her right V.A. ended in counting fingers owing to glaucomatous optic atrophy (Fig.5),
2013
Atti del Congresso
Present &Future Challenges in Severe Retinal Deseases
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11577/3179587
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
  • OpenAlex ND
social impact